Description
Latin name
Dalargin
Packaging
10 vials
Indications
Peptic ulcer of the stomach and duodenum, pancreatitis and pancreatic necrosis (in adults).
Contraindications
Tendency to hypotension, poisoning with sleeping pills and drugs, acute infectious diseases, pregnancy.
Composition of
1 ampoule contains:
Active ingredient: dalargin 1 mg
Excipients: sodium chloride, acetic acid, water d / u.
Dosage and administration
Immediately before use, the contents of the ampoule with lyophilisate are dissolved in 1 ml of isotonic sodium chloride solution.
The drug is administered in / m or / in.
In case of gastric ulcer and duodenal ulcer in the acute phase, a single dose is 1-2 mg, the maximum daily dose is 5 mg. The course of treatment is 3-4 weeks. The total dose per treatment course is 30-50 mg.
In acute pancreatitis, the drug is administered iv in a dose of 2 mg, then 5 mg 1-2 times a day. The course of treatment is 4-6 days.
In acute necrotic pancreatitis, iv is administered 5 mg 3-4 times a day (with an interval of 6-8 hours). The course of treatment is from 2 to 6 days.
Side effects
Hypotension, hyperemia, soreness (at the injection site), allergic reactions.
Storage conditions
In a dry, dark place, at a temperature not exceeding 20 ° C.
Expiration
3 years
Formulation
injection and infusion solution